Day: September 4, 2020

LA Hospital Testing Its Own High-Risk Patients in Vaccine Trial

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.



 

The patients at Dr. Eric Daar’s hospital are at high risk for serious illness from COVID-19, and he’s determined to make sure they’re part of the effort to fight the disease.

He also hopes they can protect themselves in the process.

When Daar and his colleagues at Harbor-UCLA Medical Center on Wednesday announce that they will soon begin enrollment for a trial to test a COVID-19 vaccine produced by AstraZeneca, they will also unveil the hospital’s community-based recruitment strategy.

Harbor-UCLA wants to recruit most, if not all, of the trial’s 500 participants from among the high-risk patients it already treats: people over 65, those with chronic illnesses and members of underserved racial and ethnic groups. Hospital officials also expect that the recruitment task will not be easy.

“It’s a priority and obligation to make sure our

Read More

William Kennedy’s New Book ‘A Choco-Late Concept’ Shows a Different Take on Simple and Healthy Eating – Press Release

Recent release ‘A Choco-late Concept’ from Covenant Books author William Kennedy is an informative discussion about eating healthy with tips and advices one can utilize.


CHERRY VALLEY, Ill. – August 31, 2020 – (Newswire.com)

William Kennedy, a writer from Illinois and a father of two, has completed his new book, “A Choco-late Concept”: a brilliant read that encourages self-discipline and living a healthy lifestyle.

William writes, “A Chocolate Concept is a different take on eating healthy with simplicity and fun. The author believes some parts of life don’t have to be complicated. He has a somewhat different dietary background and shares some admittedly novel ideas.”

Published by Covenant Books of Murrells Inlet, South Carolina, William Kennedy’s new book is an informative guidebook that helps readers begin a path towards a healthy lifestyle through the tips, advices, recipes, and guidelines enclosed in this creation.

Readers can purchase “A Choco-late Concept” at

Read More

COVID-19: Gym And Health Clubs Market 2020-2024 | Rising Number of Fitness Centers and Health Clubs to Boost Market Growth

LONDON–(BUSINESS WIRE)–Sep 2, 2020–

Technavio has been monitoring the gym and health clubs market and it is poised to grow by USD 20.31 billion during 2020-2024, progressing at a CAGR of almost 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200902005132/en/

Technavio has announced its latest market research report titled Global Gym and Health Clubs Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19

Read More

Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test

The Food and Drug Administration on Wednesday approved a comprehensive “liquid biopsy” platform that can detect multiple kinds of cancer and genomic alterations from pieces of tumor DNA circulating in a patient’s blood. The Foundation Medicine test, designed to identify specific types of cancer and match patients’ mutations to genetically targeted therapies, joins one approved earlier this month developed by Guardant Health.

The FDA has previously approved liquid biopsy tests for individual cancers and as so-called companion diagnostics, which identify whether patients are likely to benefit from a specific targeted drug. Foundation Medicine, a Cambridge, Mass., unit of Swiss biopharma Roche (RHBBY), has won the agency’s second nod for a pan-cancer blood assay, which combines liquid biopsy with other kinds of testing to find more diagnostic and genomic biomarkers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

Read More